3.1 Identidades presentes en la novela Tony
3.1.4 Machismo
1. At a minimum, primary care physicians need to be observant and include questions about use of CAM when taking a patient's drug medication history. This would help to diagnose any drug- CAM interaction.
2. Primary care physicians must equip themselves with the knowledge of common CAM therapies for hypertension, and hence educate their patients on the possibility of drug interactions between these CAM and conventional medications.
3. Government should draft and implement National policies and regulations to ensure sound evidence of safety efficacy and quality of CAM. There is need to device measures to ensure rational use of CAM.
4. Enactment of policies to regulate the integration of scientifically proven CAM into conventional medicine should be considered.
106 REFERENCES
1. Guerrera MP. Complementary and Alternative Medicine: integration into primary care. In: Rakel RE, Rakel DP (editors.). Textbook of Family Medicine. 8th ed. Philadelphia: Saunders; 2011. p.
131-45.
2. Weiland LS, Manheimer E, Berman BM. Development and classification of an operational definition of Complementary and Alternative medicine for the Cochrane collaboration. Altern Ther Health Med 2011;17(2):50-9
3. Fan KW. National Centre for Complementary and Alternative Medicine (NCCAM). Journal of the Medical Library Association 2005;93(3):410-2.
4. Jonas WB, Chez RA. Complementary and Alternative Medicine. In: South-paul JE, Matheney SC, Lewis EL (editors.). Current diagnosis and treatment in Family Medicine. 3rd ed NewYork (NY): McGraw-Hill; 2011. p. 537-47.
5. Singh V, Raidoo DM, Harries CS. The prevalence, patterns of usage and peoples’s attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complement Altern Med 2004;4:3.
6. Osamor PE, Owumi BE. Complementary and Alternative Medicine in the management of hypertension in an urban Nigerian community. BMC Complement. Altern Med. 2010;10:36.
7. Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Altern Med 2011;11:117.
8. Oshikoya KA, Senbanjo IO, Njokanma OF, Soipe A. Use of Complementary and Alternative Medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med 2008;8:66.
107
9. Amira OC, Okubadejo NU. Frequency of Complementary and Alternative Medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complement Altern Med 2007;7:30.
10. Olisa NA, Oyelola FT. Evaluation of use of herbal medicines among ambulatory hypertensive patients attending a secondary health care facility in Nigeria. Int J Pharm Pract 2009;17(2):101-5.
11. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment.
J Alternat Complement Med 2006;12(9):903–9
12. Mallaogu M, Aciyurt A. Use of Complementary and Alternative medicine among patients with chronic diseases. Acta Clin Croat 2013; 52(2): 181-8
13. Omogbadegun ZO, Adegboyega, MA. Frame work for overcoming barriers of complementary and alternative medicine acceptance into conventional health care system. Int J Med Plant Altern Med 2013; 1(7): 118-36.
14. Chang HY, Wallis M, Tiralongo E. Use of Complementary and Alternative Medicine among people living with diabetes: literature review. Journal of Advanced Nursing 2007;58(4):307-19.
15. Vora CK, Mansoor GA. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Curr Hypertens Rep 2005;7(4):275-8.
16. Ezeome ER, Anarado AN. Use of Complementary and Alternative Medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Altern Med 2007;7:28.
17. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacog Rev 2011;5(9):30-40.
108
18. Banwat ME, Ejimah AA, Adaji II, Kajo JI. Alternative Medicine use among workers in an Urban setting in North Central Nigeria. Intern J Biomed Res 2015;6(04):268-73.
19. 2003 WHO/ISH Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH): Statement on management of hypertension. J Hypertens 2003;21(11):1983–92.
20. Hughes GD, Aboyade OM, Clark BL, Puoane TR. The prevalence of traditional herbal medicine use among hypertensives living in South African communities. BMC complement Altern Med.
2013;13:38.
21. Bakris GL. Ritz E. Hypertension and kidney diseases: a marriage that should be prevented.
Kidney int. 2009;75:449-52.
22. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-9.
23. Sawicka K, Szczyrek M, Jastrzebska I, Prasal M, Zwolak A, Damluk J. Hypertension – The silent killer. J Pre-clin Res 2011;5(2):43-6.
24. Task Force Members. 2013 ESH / ESC Guidelines for the management of arterial hypertension:
The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens.
2013;31(4):1281–357.
25. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42:1206-52
109
26. James PA, Oparil S, Carter BL, Cushman WC, Dennison- Himmelfarb C, Handler J et al. 2014 Evidence –based guideline for the management of High blood pressure in adults:report by panel members appointed to the eight joint National Committee (JNC 8). JAMA 2014;311 (5): 501-20 27. Sutters M. Systemic hypertension. In: McPhee SJ, Papadakis MA, Tierney LM, (eds). Current
Medical Diagnosis & Treatment. 47th ed. New York: The McGraw Hill Companies Inc; 2008:
370-7.
28. Kotchen TA. Hypertensive vascular disease. In: Longo DL, Kasper DL, Jameson JL, , Fauci AS, Hauser SL, Loscalzo J, (editors). Harrison’s Principles of Internal Medicine. 18th ed. New York (NY): The McGraw Hill Companies, Inc; 2012. p. 2042-59.
29. Camm AJ, Bunce N. Cardiovascular disease. In: Kumar P, Clark M, editors. Kumar & Clark’s Clinical Medicine. 7th ed. Edinburgh: Saunders Elsevier; 2009. p.798-805.
30. Delgoda R, Ellington C, Barrett S, Gordon N, Younger N. The practice of polypharmacy involving herbal and prescription medicines in the treatment of diabetes mellitus, hypertension and gastrointestinal disorders in Jamaica. West Indian Med J 2004;53:400–5.
31. The history of complementary and alternative Medicine in the United states and beyond.
[online]. 2008 [cited 2016 Jan 10];[5 pages]. Available from: URL:http://
www.medaus.archive.com.
32. Osemene KP, Elujoba AA, Ilori MO. A Comparative Assessment of Herbal and Orthodox Medicines in Nigeria. Res J Med Sci 2011;5(5):280-5.
33. Falodun A. Herbal Medicine in Africa- distribution, standardization and prospects. Res J Phytochem 2010;4:154-61.
34. Amole OO, Yemitan OK, Oshikoya KA. Anticonvulsant activity of Rauwolfia vomitoria (Afzel).
Afri J Pharm Pharmacol 2009;3:319-22.
110
35. Lee GBW, Charn TC, Chew ZH, Ng TP. Complementary and Alternative Medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Family Practice 2004; 21(6): 654- 60.
36. Barnes PM, Bloom B. Complementary and Alternative Medicine use among adult and children:
United states, 2007. National health statistics report 2008;12:1-24.
37. Metcalfe A, Williams J, McChesney J, Patten SB and Jetté N. Use of Complementary and Alternative Medicine by those with a chronic disease and the general population - results of a national population based survey. BMC Complement Alternat Med 2010;10:58.
38. Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R et al. Complementary and Alternative Medicine use in England: results from a national survey. Int J Clin Pract.2010;64(11):1496-502.
39. Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and Alternative Medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13(6):643-50.
40. Fonnebo V, Launso L. High use of Complementary and Alternative Medicine inside and outside of the government-funded health care system in Norway. J Altern Complement Med 2009;15(10):1061-6.
41. Hanssen B, Grimsgaard S, Launso L, Fonnebo V, Falkenberg T, Rasmussen NK. Use of Complementary and Alternative Medicine in the Scandinavian countries. Scand J Prim Health Care.2005;23(1):57-62.
42. Ock SM, Choi JY, Cha YS, Lee J, Chun MS, Huh CH et al. The use of Complementary and Alternative Medicine in a general population in South Korea: results from a national survey in 2006. J Korean Med Sci. 2009;24(1):1–6.
111
43. Hughes GD, Oluwaseyi M. Aboyade OM, Beauclair R, Mbamalu ON, Thandi R et al.
Characterizing herbal Medicine use for non-communicable diseases in urban South Africa. Evid Based Complement Alternat Med 2015; 2015:736074.
44. Okoronkwo I, Onyia-pat J, Okpala P, Agbo M, Ndu A. Patterns of Complementary and Alternative Medicine use, Perceived benefits, and adverse effects among Adult users in Enugu urban, Southeast Nigeria. Evid Based Complement Alternat Med 2014;2014:239372
45. Abodurin OL, Omojasola TP, Rojugbokan OO. Utilization of alternative medical services in an urban centre of North central Nigeria. The Nigerian Health Journal 2011;11(2):51-5.
46. Igoli JO, Ogaji OG, Tor-Anyiin TA, Igoli NP.Traditional medicine practice amongst the Igede people of Nigeria. Part II. Afr J Trad Complement Altern Med 2005; 2(2):134-52.
47. Adeyeye OO, Onadeko BO, Ogunleye O, Bamisile RT, Olubusi A. The use of Complementary and Alternative Medicine by asthma patients receiving care in an urban tertiary centre in Nigeria.
Int J Biol Med Res 2011; 2(4):1026-30.
48. Idung UI, Udoh SB, Abasiubong F. Complementary and alternative medicine Use among HIV infected patients on antiretroviral therapy in the Niger Delta region, Nigeria. IOSR J Med Dent Sci 2014;13(1):26-31.
49. Artus M, Croft P, Lewis M. The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain. BMC Family Practice 2007;8:26.
50. Wazaify M, Alawwa IA, Yasein N, Saleh A, Afifi E. Complementary and Alternative Medicine use among Jordanian patients with chronic diseases. Complement ther clin pract 2013;19(3):153-7.
51. Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S. Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol 2015;4(3):217-20.
112
52. Namuddu B, Kalyango JN, Karamagi C, Mudiope P, Sumba S, Kalende H. Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health. 2011;11:855.
53. Gohar F, Greenfield SM, Beevers DG, Lip GYH, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008;8:4.
54. Hu H, Li G, Duan J, Aroa T. Prevalence, Purposes, and Perceived Effectiveness of
Complementary and Alternative Medicine Use in a Hypertension Population: A Questionnaire Survey. ISRN Public Health [serial online] 2013 [cited 2015 Dec 12];2013:[7 pages]. Available from: URL: http:/dx.doi.org/10.115/2013/137472
55. Shafiq N, Gupta M, Kumari S, Pandhi P. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. Int J Clin Pharmacol Ther. 2003;41(7):294-8.
56. Siew-mooi C, Vasudevan R, Zakaria ZA, Paimin F. Frequency of Complementary and Alternative Medicine usage among Malaysian hypertensive subjects . Life Sci J 2013;10(4):1045-67.
57. Mahfudz AS, Chan SC. Use of Complementary Medicine amongst hypertensive patients in a primary care clinic in Ipoh. Med J Malaysia 2005; 60(4):454- 9.
58. Ali-Shtayeh M, Jamous RM, Salameh NMY. Complementary and Alternative medicine (CAM) use among hypertensive patients in Palestine. Complement Ther Clin Pract 2013;19:256-63.
59. Liwa AC, Smart LR, Frumkin A, Epstein HB, Fitzgerald DW, Peck RN. Traditional Herbal Medicine use among Hypertensive Patients in Sub-Saharan Africa: A systematic review. Curr Hypertens Rep 2014;16:437-9.
113
60. Peltzer K. Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural South African Hospital. Curationis. 2004;27:15–23.
61. Nuwaha F, Musinguzi G. Use of alternative medicine for hypertension in Buikwe and Mukono districts of Uganda: a cross sectional study. BMC Complement Altern Med 2013;13: 301.
62. Kretchy IA, Owusu-Daaku F, Danquah S. Patterns and determinants of the use of Complementary and Alternative Medicine: a cross-sectional study of hypertensive patients in Ghana. BMC Complement Altern Med 2014;14:44.
63. Adeyemo AA, Omotade OO, Rotimi CN, Luke AH, Tayo BO, Cooper RS. Heritability of blood pressure in Nigerian families. J Hypertens. 2002;20(5):859–63.
64. Mahomoodally MF. Traditional Medicines in Africa: An Appraisal of Ten Potent African Medicinal Plants. Evid Based Complement Alternat Med [serial online] 2013 [cited 2016 Jan 10];
2013:[14 pages]. Available from:URL:
http://dx.doi.org/10.115/2013/617459
65. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006; 27(1):1–93.
66. Chintamunnee V, Mahomoodally MF. Herbal medicine commonly used against infectious diseases in the tropical island of Mauritius. J Herb Med 2012; 2:113–25.
67. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: A systematic review and meta-analysis. BMC Cardiovasc Disord 2008;8:13.
68. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother 2008;42:1766-71.
114
69. Dhawan V, Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem 2005;275:85-94.
70. Wang H, Yang J, Qin L, Yang X. Effect of Garlic on Blood Pressure: a meta-analysis. J Clin Hypertens 2015;17(3):214-35
71. Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: A food plant with multiple medicinal uses. Bioresource Technology 2007;98(1):232-6.
72. Varmani SG, Garg M. Health benefits of Moringa Oleifera; A miracle tree. Intern J Food Nutr Sci 2014;3(3):51-62.
73. Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study.
Am Heart J 2006;151:100-14.
74. Paran E, Novack V, Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertension patients. Cardiovasc Drugs Ther 2009;23:145-51.
75. Mojiminiyi FB, Dikko M, Muhammad BY, Ojobor PD, Ajagbonna OP, Okolo RU, et al.
Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa. Fitoterapia 2007;78:292-7.
76. Sarr M, Ngom S, Kane MO, Wele A, Diop D, Sarr B, et al. In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta. Nutr Metab 2009;6:45-56
77. Hopkins AL, Lamm MG, Funk J, Ritenbaugh C. Hibiscus Sabdariffa in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.
Fitoterapia 2013;85:84-94.
115
78. Jerie P. Milestones of cardiovascular therapy: IV, Reserpine. Cas Lak Cesk 2007;146:573-7.
79. Zadeh JB, Kor NM. Physiological and pharmaceutical effects of Ginger (Zingiber officinale Roscoe) as a valuable medicinal plant. Eur J of Experiment Biol 2014;4(1):87-90.
80. Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): A hot remedy for cardiovascular disease? Int J Cardiol 2009;131:408-9.
81. Nwokocha CR, Owu DU, McLaren M, Murray J, Delgoda R, Thaxter K et al. Possible mechanisms of action of the aqueous extract of Artocarpus altilis (breadfruit) leaves in producing hypotension in normotensive Sprague-Dawley rats. Pharm Biol.2012;50(9):1096-102.
82. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: A summary of a statement for professionals from the American Heart Association nutrition committee. Arterioscler Thromb Vasc Biol 2006;26:1689-92.
83. Amaechina FC, Omogbai EK. Hypotensive effect of aqueous extract of the leaves of Phyllanthus amarus Schum and Thonn (Euphorbiaceae). Acta Pol Pharm 2007;64:547-52.
84. Ladeji O, Udoh FV, Okoye ZS. Activity of aqueous extract of the bark of Vitex doniana on uterine muscle response to drugs. Phytother Res 2005;19:804-6.
85. Hasrat JA, Pieters L, Vlietinck AJ. Medicinal plants in Suriname. J Pharm Pharmacol 2004;56:381-7.
86. Stowe CB. The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement Ther Clin Pract.2011 May;17(2):113-5.
87. Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S, Rafieian-Kopaei M.
Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic
116
and anti-Inflammatory effects of pomegranate juice in hypertensive Subjects. Phytother Res 2014;28( 2): 193–9.
88. Sahebkar A, Ferri C, Giorgini P, Bo S, Nachtigal P, GrassiD. Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials.
Pharmacol Res 2017;115:149-61.
89. Behall KM, Scholfield DJ, Hallfrisch J. Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J Am Diet Assoc 2006;106:1445-9.
90. Ofem OE, Eno AE, Imoru J, Nkanu E, Unoh F, Ibu JO. Effect of crude aqueous leaf extract of Viscum album (mistletoe) in hypertensive rats. Indian J Pharmacol 2007;39:15-9.
91. Ben EE, Eno AE, Ofem OE, Aidem U, Itam EH. Increased plasma total cholesterol and high density lipoprotein levels produced by the crude extract from the leaves of Viscum album (mistletoe). Niger J Physiol Sci 2006;21:55-60.
92. AfolayanAJ, Wintola OA. Dietary supplements in the management of hypertension and diabetes - a review. Afr J Tradit Complement Altern Med 2014;11(3):248–58.
93. Bellows I, Moore R. Water-soluble vitamins: B- complex and vitamin C. Colorado State University; 2012. Cooperative Extension fact sheet No. 9.312.
94. Mori TA, Burke V, Puddey I, Irish A, Cowpland CA, Beilin L et al. The effects of omega 3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens 2009;27(9):1863-72.
95. Houston MC. Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Expert Rev Cardiovasc Ther 2007;5:681–91.
117
96. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al.: Risks and benefits of omega-3 fats for mortality, cardiovascular disease, and cancer: a systematic review.
Br Med J 2006;332:752-60.
97. Fujii H, Iwase M, Ohkuma T, Ogata-Kaizu S, Ide H, Kikuchi Y et al. Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Nutr J 2013;12:159-74.
98. Evans C E.L, Greenwood D C, Threapleton DE, Cleghorn C L, Nykjaer C, Woodhead CE et al.
Effects of dietary fibre type on blood pressure: a systematic review and meta-analysis of randomized controlled trials of healthy individuals. J hypertens 2015;5(33):897-911.
99. Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension.
World J Cardiol 2014;6(2):38–66.
100. Juraschek SP, Guallar E, Appel LP, Miller ER. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;95(5):1079-88 101. Wang J, Xiong XJ. Current situation and perspectives of clinical study in integrative medicine in
China. Evid Based Complement Alternat Med 2012;2012:1–11
102. Liu SC, Wang HX, Hou XM. Clinical research of modified qi ju dihuang decoction on resistant hypertension in elderly. J Emerg Tradit Chin Med 2011;20:1729–30.
103. Zhu ZP, Peng C. Effect of warming kidney yang therapy combined with western medicine on 23 cases of resistant hypertension. J Sichuan Tradit Chin Med 2012;30:83–4.
104. Macklin EA, Wayne PM, Kalish LA, Valaskatgis P, Thompson J, Pian-Smith MC et al. Stop hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial. Epub 2006;48(5):838-45
118
105. Kretzer K, Davis J, Easa D. Self identity through Ho’oponopono as adjunctive therapy for hypertension management. Ethn Dis 2007;17(4):624–8.
106. Kretzer K. Integrating a CAM therapeutic strategy for hypertension. Am J Nurse Pract.
2011;15(11-12): 48–52.
107. Greenhalgh J, Dickson R, Dundar Y. Biofeedback for hypertension: a systematic review. J Hypertens. 2010;28(4):644-52.
108. Posadzki P, Cramer H, Kuzdal A, Lee MS, Ernst E. Yoga for hypertension: a systematic review of randomized clinical trials. Complement Ther Med 2014;22:511-22.
109. Bijlani RL, Vempati RP, Yadav RK, Ray RB, Gupta V. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med 2005;11:267-74.
110. Hagins M, Rundle A, Consedine NS, Khalsa SBS. A randomized controlled trial comparing the effects of yoga to an active control on ambulatory blood pressure in individuals with pre- and stage 1 hypertension. J Clin Hypertens 2014;16(1):54-62.
111. Wang J, Xiong X, Liu W. Yoga for essential hypertension: a systematic review. PLoS ONE 2013;8(10):e76357
112. Lokita AA, Mabuza LH, Okonta HI. Reasons given by hypertensive patients for concurrently using traditional and western medicine at Natalspruit Hospital in the Gauteng Province, South Africa. Afr J Prm Healthcare Fam Med 2013;5(1):1-7.
113. Ernst E. Why Alternative medicines are used. Pharmaceutical Journals 2005;275:55-68
114. Humidat AS, Khamaysa IS. The use of herbal medicines by people with hypertension in Palestine. International Journal of Technology Enhancement and Engineering Research 2014;2(7):131-134
119
115. Jimoh AO, Bakare AT. Safety perception and knowledge of commonly used Complementary and Alternative Medicine among physicians in Usmanu Danfodiyo University Teaching Hospital Sokoto, North-Western Nigeria. Sahel Med J 2014;17:140-4
116. Nita M, Alison S. Academic doctors' views of Complementary and Alternative Medicine (CAM) and its role within the NHS: An exploratory qualitative study. BMC Complement Altern Med 2007;7:17
117. Benue state, Nigeria’s Food Basket. [online]. [cited 2015 Jul 20]; Available from URL:http://benuestate.gov.ng/wp/about us/the-state-capital/.
118. National Population Commission (2008). Report of 2006 National Census Abuja. NPC 2008.
www.population.gov.ng/index.php.
119. Aroaye MO. Research methodology with statistics for health and social sciences. Ilorin : Nathadex;2004.p115-122
120. Isioma OM, Purity N. Influence of cultural and traditional practices on the management and prevention of hypertension in some rural settlements in Delta State, Nigeria. Br J Med Health Res 2015;2(3):294-311.
120 APPENDIX 1 LETTER OF CONSENT
I……….of………
………..
do hereby consent to participate in this study titled: The concurrent use of complementary and alternative medicine with orthodox medicine among adult hypertensives attending the general outpatient clinic of the Benue State University Teaching Hospital , Makurdi. I acknowledge that I have been properly counselled on the implications of my involvement. I understand that the information i would give for the course of this study is solely for the purpose of medical research and I express my willingness to participate on the understanding that I shall be entitled to withdraw from the study at any time I choose to do so.
Date………. Signed ………
I confirm that I have explained to the patient the purpose and nature of this study and his/her refusal to participate will not in any way affect the normal care by me or any member of this institution. I know the consequences of any false declaration on this or any other form.
Date………. Signed………
(Doctor/researcher)
121 APPENDIX I1 Participant Serial Number...
QUESTIONNAIRE Introduction
Good day Sir./ma This study aims to evaluate the concurrent use of complementary and alternative medicines among adult hypertensives attending the general outpatient clinic of the Benue State University Teaching Hospital, Makurdi. In order to achieve this goal, your participation and co-operation is highly needed. You are required to fill the attached consent form indicating that you have agreed to participate in the study. Responses to this questionnaire will be treated with absolute confidentiality.
Kindly tick only one response for each question or information required except where otherwise instructed. Where blank spaces exist, kindly fill them with the appropriate answer(s).
Thank you for your cooperation.
Section A: Socio-demographic data
1. Age (years): 2. Sex male [ ] female [ ] 3. Marital status :
(a) Single (b) Married (c) Separated (d) Divorced (e) Widowed
122 4. Highest educational level attained:
(a) No formal education (b) Primary (c) Secondary (d) Tertiary
5. Occupation :
(a) Unemployed (b) Student (c) Civil servant (d) Retired
(e) Professional (f) Farmer
(g) Business executive (h) others (specify)...
6. Ethnic group : Tiv { } Idoma { } Igede { } Igbo{ } Hausa{ } Yoruba{ } others(
specify ) { }
7. Religion: a. Christianity { } b. Islam { } c. Others (specify please) { } Section B: History of hypertension and CAM usage
8. How long have you had hypertension?
<1yr { } 1-5yrs { } 6-10yrs{ } >10yrs{ } 9. Are you currently taking medications for hypertension?
Yes No
10. How many drugs ( antihypertensives) are you taking presently?
1{ } 2{ } 3{ } 4{ } >4 { } I don’t know { }